Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 3/20 | 0.41 |
| ▸ | ESR2 | Q92731 | 3/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | KCNN4 | O15554 | 3/20 | 0.31 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2816468 | 0.86 | ALDH1A1 (0.39) | ESR1ESR2MAPK1ALDH1A1TAAR1 | |
| SCHEMBL9872415 | 0.83 | KCNN4 (0.35) | MAPK1ALDH1A1TAAR1ALOX15KDM4E | |
| SCHEMBL198144 | 0.82 | KCNN4 (0.32) | ALDH1A1KCNN4TSHR | |
| SCHEMBL1820792 | 0.79 | KDM4E (0.30) | KDM4EMAPTKMT2A | |
| Benzene SCHEMBL4593432 | 0.78 | TSHR (0.38) | ALDH1A1MAPTTSHR | |
| SCHEMBL28872444 | 0.78 | KCNN4 (0.48) | KCNN4 | |
| Biphenyl SCHEMBL9539322 | 0.77 | ALDH1A1 (0.33) | MAPK1ALDH1A1KMT2AKCNN4 | |
| SCHEMBL8115695 | 0.73 | KDM4E (0.35) | ALDH1A1ALOX15KDM4EKMT2AKCNN4 | |
| SCHEMBL30139540 | 0.73 | KIF11 (0.40) | ALDH1A1KDM4E | |
| SCHEMBL16975529 | 0.73 | KIF11 (0.37) | ALDH1A1CYP3A4MAPTCYP2C19TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5502191-A | CYCLIZATION, INTERMEDIATES FOR ANGIOTENSIN II RECEPTOR ANTAGONISTS | AMERICAN CYANAMID COMPANY (US) | 1996-03-26 | — | — | US | disclosed |